Carlos Javier Alméciga-Díaz

22PUBLICATIONS
37CO-AUTHORS
NeurogeneticsGlycoconjugatesCeramicsCheminformatics and quantitative structure-activity relationshipsImmunogenetics (incl. genetic immunology)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (22)

|Feb 27, 2026
Evaluation of GlcNAc-Configured Glycomimetics as Pharmacological Chaperones of NAGLU for the Treatment of Mucopolysaccharidosis IIIB.

Nissrine Ballout, Jérôme Désiré, Angela Johana Espejo-Mojica

|May 14, 2025
CRISPR/nCas9-Edited CD34+ Cells Rescue Mucopolysaccharidosis IVA Fibroblasts Phenotype.

Angélica María Herreno-Pachón, Andrés Felipe Leal, Shaukat Khan

|Sep 28, 2024
Study of Potential Blocking Peptides Targeting the SARS-CoV-2 RBD/hACE2 Interaction.

Sara M Villada-Troncoso, Jenny Andrea Arévalo-Romero, Vanessa Hernández Rivera

|Nov 25, 2023
Mucopolysaccharidosis IVA: Current Disease Models and Drawbacks.

Andrés Felipe Leal, Carlos Javier Alméciga-Díaz, Shunji Tomatsu

|Jul 29, 2023
Humoral Immune Response of Mice against a Vaccine Candidate Composed of a Chimera of gB of Bovine Alphaherpesviruses 1 and 5.

Juan Sebastian Quintero Barbosa, Carlos Javier Alméciga-Díaz, Sandra E Pérez

Pageof 4